Amgen (AMGN), Onyx (ONXX) Deal Will Go Through Pending New Kyprolis Data
Tweet Send to a Friend
Onyx Pharmaceuticals (Nasdaq: ONXX) is lower Monday amid continued speculation over how quickly Amgen (Nasdaq: AMGN) might pursue a deal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE